Microbot Medical (NASDAQ: MBOT) announced today that it has validated the operational effectiveness of the Company’s Self-Cleaning Shunt (SCSTM) in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Microbot Medical (MBOT) Sees Red to Green ReversalJanuary 15, 2019 9:39 AM Microbot Medical (MBOT) Prices 455K Share Registered Direct Common Offer at $6.50/Sh January 15, 2019 8:07 AM Microbot Medical (MBOT) Surges on Effectiveness of Self-Cleaning Shunt in StudyJanuary 14, 2019 9:00 AM Recent Study Validates the Operational Effectiveness of Microbot Medical’s Self-Cleaning Shunt (SCS™)January 14, 2019 7:01 AM